Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC | Benzinga

Q: What sector and industry does Vincerx Pharma (VINC) operate in?

Vincerx Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Vincerx Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VINC.

Open	$0.26
Close	-
Volume / Avg.	572.05K / 1.12M
Day Range	$0.24 - $0.27
52 Wk Range	0.10 - 20.80
Market Cap	$571.12K
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	24
Short Interest	6.76%
Days to Cover	1

Recent News

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Avi Kapoor

Nasdaq Gains Over 100 Points; Delta Air Lines Posts Upbeat Earnings

Avi Kapoor

US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert

U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following Donald Trump's 104% tariff on China.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.26
Close	-
Volume / Avg.	572.05K / 1.12M
Day Range	$0.24 - $0.27
52 Wk Range	0.10 - 20.80
Market Cap	$571.12K
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	24
Short Interest	6.76%
Days to Cover	1

About Vincerx Pharma Inc

Sector

Health Care

Industry

Biotechnology

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology...

Got Questions? Ask

What is VINC's 200-day MA?

What is VINC's 5 years max drawdown?

What is VINC's operating cash flow?

What is VINC's P/E ratio?

What is VINC's P/S ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vincerx Pharma (VINC) stock?

You can purchase shares of Vincerx Pharma (NASDAQ:VINC) through any online brokerage.

View our list of the best stock brokerages

Who are Vincerx Pharma (VINC) competitors?

Other companies in Vincerx Pharma’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), ZyVersa Therapeutics (NASDAQ:ZVSA), Entero Therapeutics (NASDAQ:ENTO), Bone Biologics (NASDAQ:BBLG) and Scinai Immunotherapeutics (NASDAQ:SCNI).

What is the forecast, or price target, for Vincerx Pharma (VINC) stock?

Vincerx Pharma has a consensus price target of $4.00.

What is the current price for Vincerx Pharma (VINC)?

The stock price for Vincerx Pharma (NASDAQ: VINC) is $0.2621 last updated April 14, 2025 at 8:52 AM EDT.

Does Vincerx Pharma (VINC) pay a dividend?

There are no upcoming dividends for Vincerx Pharma.

When is Vincerx Pharma (NASDAQ:VINC) reporting earnings?

Vincerx Pharma’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Vincerx Pharma (VINC) going to split?

There is no upcoming split for Vincerx Pharma.

What sector and industry does Vincerx Pharma (VINC) operate in?

Vincerx Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Vincerx Pharma Stock Price, Quotes and Forecasts

Vincerx Pharma (VINC) Forecast